Because studies of this type of cell death have not been sufficiently powerful, novel active compounds are required to distinguish the contributions of caspase-1/3/11 to the pyroptotic signaling pathway in HNSCC. The gene discussed is CASP1; the disease is head and neck squamous cell carcinoma.